Standard
Cardiovascular effects of growth hormone in adult hemodialysis patients: results from a randomized controlled trial. / Køber, Lars; Rustom, Rana; Wiedmann, Jonas; Kappelgaard, Anne-Marie; El Nahas, Meguid; Feldt-Rasmussen, Bo.
In:
Nephron Clinical Practice, Vol. 115, No. 3, 01.01.2010, p. c213-26.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Køber, L, Rustom, R, Wiedmann, J, Kappelgaard, A-M, El Nahas, M
& Feldt-Rasmussen, B 2010, '
Cardiovascular effects of growth hormone in adult hemodialysis patients: results from a randomized controlled trial',
Nephron Clinical Practice, vol. 115, no. 3, pp. c213-26.
https://doi.org/10.1159/000313038
APA
Køber, L., Rustom, R., Wiedmann, J., Kappelgaard, A-M., El Nahas, M.
, & Feldt-Rasmussen, B. (2010).
Cardiovascular effects of growth hormone in adult hemodialysis patients: results from a randomized controlled trial.
Nephron Clinical Practice,
115(3), c213-26.
https://doi.org/10.1159/000313038
Vancouver
Køber L, Rustom R, Wiedmann J, Kappelgaard A-M, El Nahas M
, Feldt-Rasmussen B.
Cardiovascular effects of growth hormone in adult hemodialysis patients: results from a randomized controlled trial.
Nephron Clinical Practice. 2010 Jan 1;115(3):c213-26.
https://doi.org/10.1159/000313038
Author
Køber, Lars ; Rustom, Rana ; Wiedmann, Jonas ; Kappelgaard, Anne-Marie ; El Nahas, Meguid ; Feldt-Rasmussen, Bo. / Cardiovascular effects of growth hormone in adult hemodialysis patients: results from a randomized controlled trial. In: Nephron Clinical Practice. 2010 ; Vol. 115, No. 3. pp. c213-26.
Bibtex
@article{fb933a155f1e45a388f31cac7e85d295,
title = "Cardiovascular effects of growth hormone in adult hemodialysis patients: results from a randomized controlled trial",
abstract = "The high morbidity and mortality rates in hemodialysis (HD) patients are due, at least in part, to their increased risk for cardiovascular diseases (CVD). This prospective study evaluated the effect of growth hormone (GH) on a number of CVD risk markers in adult patients on HD.",
author = "Lars K{\o}ber and Rana Rustom and Jonas Wiedmann and Anne-Marie Kappelgaard and {El Nahas}, Meguid and Bo Feldt-Rasmussen",
note = "Copyright 2010 S. Karger AG, Basel.",
year = "2010",
month = jan,
day = "1",
doi = "http://dx.doi.org/10.1159/000313038",
language = "English",
volume = "115",
pages = "c213--26",
journal = "Nephron - Clinical Practice",
issn = "1660-8151",
publisher = "S Karger AG",
number = "3",
}
RIS
TY - JOUR
T1 - Cardiovascular effects of growth hormone in adult hemodialysis patients: results from a randomized controlled trial
AU - Køber, Lars
AU - Rustom, Rana
AU - Wiedmann, Jonas
AU - Kappelgaard, Anne-Marie
AU - El Nahas, Meguid
AU - Feldt-Rasmussen, Bo
N1 - Copyright 2010 S. Karger AG, Basel.
PY - 2010/1/1
Y1 - 2010/1/1
N2 - The high morbidity and mortality rates in hemodialysis (HD) patients are due, at least in part, to their increased risk for cardiovascular diseases (CVD). This prospective study evaluated the effect of growth hormone (GH) on a number of CVD risk markers in adult patients on HD.
AB - The high morbidity and mortality rates in hemodialysis (HD) patients are due, at least in part, to their increased risk for cardiovascular diseases (CVD). This prospective study evaluated the effect of growth hormone (GH) on a number of CVD risk markers in adult patients on HD.
U2 - http://dx.doi.org/10.1159/000313038
DO - http://dx.doi.org/10.1159/000313038
M3 - Journal article
VL - 115
SP - c213-26
JO - Nephron - Clinical Practice
JF - Nephron - Clinical Practice
SN - 1660-8151
IS - 3
ER -
